The U.S. bone graft substitute market will reach $2.3 billion by 2015, a result of the adoption of new growth factors and improved features of newer products, according to a release from the Millennium Research Group.
In addition to new products such as Medtronic's Amplify, which combines collagen and ceramic matrix designed for implantation in single-level posterolateral lumbar fusions, next year's bone graft substitute market will include technology from BioMimetic Therapeutics, a platelet-derived growth factor. Additional products, such as NuVasive's Osteocel Plus, Orthofix's Trinity Evolution and AlloSource's AlloStem will continue to utilize stem cell technology to promote issue cell growth and bone healing.
MRG's US Markets for Orthopedic Biomaterials 2010 report includes trends for fuel product adoption and market growth for graft substitutes, cell concentration systems and knee cartilage repair.
Read the Millennium Research Group's release on the bone graft substitute market.
Read other coverage on bone graft substitutes:
- FDA Clears Osteoinductive Bone Graft Substitute From Wright Medical Group
- Etex's EquivaBone bone Graft Substitute Wins FDA Clearance for More Uses
- FDA Panel Votes to Recommend Approval for Medtronic's Amplify Spine Device
In addition to new products such as Medtronic's Amplify, which combines collagen and ceramic matrix designed for implantation in single-level posterolateral lumbar fusions, next year's bone graft substitute market will include technology from BioMimetic Therapeutics, a platelet-derived growth factor. Additional products, such as NuVasive's Osteocel Plus, Orthofix's Trinity Evolution and AlloSource's AlloStem will continue to utilize stem cell technology to promote issue cell growth and bone healing.
MRG's US Markets for Orthopedic Biomaterials 2010 report includes trends for fuel product adoption and market growth for graft substitutes, cell concentration systems and knee cartilage repair.
Read the Millennium Research Group's release on the bone graft substitute market.
Read other coverage on bone graft substitutes:
- FDA Clears Osteoinductive Bone Graft Substitute From Wright Medical Group
- Etex's EquivaBone bone Graft Substitute Wins FDA Clearance for More Uses
- FDA Panel Votes to Recommend Approval for Medtronic's Amplify Spine Device